REDEMPLO FDA approval date

The FDA approved REDEMPLO on 18 Nov 2025.

FDA approval date
18 Nov 2025

Drug identity has not yet been verified against registry records

Also recorded as PLOZASIRAN SODIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-11-18DayREDEMPLOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA219947", "applicant_as_listed_by_fda": "ARROWHEAD", "brand_names": ["REDEMPLO"], "active_ingredients": ["PLOZASIRAN SODIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251118", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026